BMS and Sanofi-Aventis issued civil investigative demands

Share this content:
The FTC has issued civil investigative demands, which act like subpoenas, to Bristol-Myers Squibb and Sanofi-Aventis for documents relating to efforts to delay Apotex and other competition for Plavix (clopidogrel bisulfate).

Share this content:
Scroll down to see the next article